Origin Energy (ASX: ORG) delivers A$911m APLNG dividend but flags FY27 decline as data breach exposes 900,000 customers
Read More Pharma Industry News Abbott adds colorectal cancer blood test to Cologuard portfolio after Freenome FDA win Freenome wins FDA approval for SimpleScreen CRC, triggering a $100 million Abbott payment and setting up a fall U.S. launch. bySoujanya RaviJuly 29, 2026